Gray matter abnormalities associated with duration of untreated psychosis.
about
Gender and duration of untreated psychosis: a systematic review and meta-analysisThe myth of schizophrenia as a progressive brain diseaseThe role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosisThe effects of antipsychotic treatment on cerebral structure and function in schizophrenia.What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersThe 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.Untreated illness duration correlates with gray matter loss in first-episode psychoses.Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis.Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophreniaMethamphetamine users show greater than normal age-related cortical gray matter loss.Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia.Brain derived neurotropic factor in first-episode psychosis.Focal and global brain measurements in siblings of patients with schizophreniaDuration of Untreated Psychosis and Brain Function during Verbal Fluency Testing in First-Episode Schizophrenia: A Near-Infrared Spectroscopy Study.Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: a voxel-based structural MRI studyCognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients.Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophreniaCerebral disconnectivity: an early event in schizophrenia.Early detection and intervention of psychosis. A review.Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect.Treatment implications of the schizophrenia prodrome.Does active psychosis cause neurobiological pathology? A critical review of the neurotoxicity hypothesis.Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes.Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis.Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.
P2860
Q22242298-EB220E44-B236-4294-91B5-8D269CB3A6CEQ24067152-831CEAD5-0BF0-42D3-95D4-898B57E9F10BQ28083246-8444ED4B-0B95-439D-BB41-86A0A00D1B14Q31120604-B49D7D19-A79D-4335-AC26-1C5794AC3179Q31147040-DD714D9F-F9C6-4454-B758-FA17B304661CQ34095720-992B2BC4-8BA5-4C74-9406-11A0B20B2FCEQ34279073-B1BE62F9-0AB1-4128-9B8D-CC724E03C31EQ34415284-A5EF9A45-CD7E-4D22-ACD7-53A1BA17A55CQ34512489-634D47BA-E7C5-4DE6-BBF7-C4B2F7DE9C3FQ35082568-93ABA137-E9A8-4E20-B00C-FA9A691AEA39Q35103520-422782C9-3126-49D4-A960-A863ED3F164AQ35786727-D1BE0BEE-8F3F-40C0-A7FD-8DCEBB403F11Q35914742-75107EE4-562B-4195-ACB6-76FE2E3E6A75Q36121493-DEF336E7-361E-4656-A081-D2EC725B2145Q36361092-869AABC3-DB64-4FAD-A983-075D618DCE75Q36693346-B9141BA4-BC9D-4A99-BF67-169747A88797Q36812828-7B5CB00B-EC0D-4A19-8D7F-DF2759735F08Q36957729-1BD46602-0AE0-40A7-9E1B-97C85E120CEBQ36958178-E34E8862-407E-4932-AC66-45541BB5A76CQ37196812-8AFADDA7-A27C-4561-8415-FDE6A45CAE3FQ37203352-C2EFAA93-8A59-4116-9FCC-17E9D4DD0CACQ37839923-DE3CF001-44C6-4AA1-AB60-847E8D046EE5Q38143298-E4FE1B0B-5C74-4458-ABC8-95790AB23B99Q40022563-AF94FEB8-0763-4B44-A277-6C8A303D8330Q44897333-8D489CC7-D656-4E6F-B39D-980AF61E45FFQ47668735-F001A868-AB49-4A55-83A3-17AC643DE7EDQ48732182-27F3D499-DDAC-42FB-BD1B-AE728E8BEA80Q50925476-3CF9D70A-07C9-44EF-B405-CDC94CF95D99
P2860
Gray matter abnormalities associated with duration of untreated psychosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Gray matter abnormalities associated with duration of untreated psychosis.
@en
Gray matter abnormalities associated with duration of untreated psychosis.
@nl
type
label
Gray matter abnormalities associated with duration of untreated psychosis.
@en
Gray matter abnormalities associated with duration of untreated psychosis.
@nl
prefLabel
Gray matter abnormalities associated with duration of untreated psychosis.
@en
Gray matter abnormalities associated with duration of untreated psychosis.
@nl
P2093
P50
P1476
Gray matter abnormalities associated with duration of untreated psychosis.
@en
P2093
Gerard Hutchison
Julian Leff
Paul Fearon
Xavier Chitnis
P304
P356
10.1016/J.SCHRES.2005.11.018
P407
P50
P577
2006-01-31T00:00:00Z